These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26534896)

  • 1. A novel endolysin disrupts Streptococcus suis with high efficiency.
    Ji W; Huang Q; Sun L; Wang H; Yan Y; Sun J
    FEMS Microbiol Lett; 2015 Dec; 362(24):fnv205. PubMed ID: 26534896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.
    Zhang H; Zhang C; Wang H; Yan YX; Sun J
    FEMS Microbiol Lett; 2016 Sep; 363(18):. PubMed ID: 27481700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.
    Tang F; Li D; Wang H; Ma Z; Lu C; Dai J
    Appl Environ Microbiol; 2015 Nov; 81(21):7377-84. PubMed ID: 26253669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection.
    Xiao Y; Chen R; Li M; Qi Z; Yu Y; Pan Z; Yao H; Feng Z; Zhang W
    Arch Microbiol; 2021 Oct; 203(8):5163-5172. PubMed ID: 34338822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics.
    Lebel G; Piché F; Frenette M; Gottschalk M; Grenier D
    Peptides; 2013 Dec; 50():19-23. PubMed ID: 24096107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen.
    Vázquez R; Domenech M; Iglesias-Bexiga M; Menéndez M; García P
    Sci Rep; 2017 Nov; 7(1):16506. PubMed ID: 29184097
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhao F; Yang N; Wang X; Mao R; Hao Y; Li Z; Wang X; Teng D; Fan H; Wang J
    Front Cell Infect Microbiol; 2019; 9():48. PubMed ID: 30863725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amentoflavone Ameliorates Streptococcus suis-Induced Infection
    Shen X; Niu X; Li G; Deng X; Wang J
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30315078
    [No Abstract]   [Full Text] [Related]  

  • 9. LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci.
    Donovan DM; Foster-Frey J
    FEMS Microbiol Lett; 2008 Oct; 287(1):22-33. PubMed ID: 18673393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation and characterization of a Streptococcus suis serotype 9 from a wild cat].
    Tang F; Pan Z; Li D; Ma L; Xiong Y; Lu C
    Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):275-82. PubMed ID: 27373075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
    Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lytic phages and prophages of Streptococcus suis--a review].
    Tang F; Lu C
    Wei Sheng Wu Xue Bao; 2015 Apr; 55(4):389-94. PubMed ID: 26211312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Phage Lysin Ply5218 in the Treatment of
    Wang Z; Ma J; Wang J; Yang D; Kong L; Fu Q; Cheng Y; Wang H; Yan Y; Sun J
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31387285
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective Antibacterial and Antihemolysin Activities of Ellipticine Hydrochloride against Streptococcus suis in a Mouse Model.
    Wang C; Lu H; Liu M; Wang G; Li X; Lu W; Dong W; Wang X; Chen H; Tan C
    Appl Environ Microbiol; 2021 Apr; 87(10):. PubMed ID: 33674433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance and prudent drug use for Streptococcus suis.
    Varela NP; Gadbois P; Thibault C; Gottschalk M; Dick P; Wilson J
    Anim Health Res Rev; 2013 Jun; 14(1):68-77. PubMed ID: 23683342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain.
    Donovan DM; Foster-Frey J; Dong S; Rousseau GM; Moineau S; Pritchard DG
    Appl Environ Microbiol; 2006 Jul; 72(7):5108-12. PubMed ID: 16820517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection.
    Li XX; Zhang FQ; Wang S; Duan XC; Hu DY; Gao DY; Tao P; Li XM; Qian P
    J Antimicrob Chemother; 2023 Mar; 78(3):747-756. PubMed ID: 36659862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.
    Gilmer DB; Schmitz JE; Thandar M; Euler CW; Fischetti VA
    PLoS One; 2017; 12(1):e0169180. PubMed ID: 28046082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TREM-1 Signaling in the Presence of Antibiotics is Effective Against Streptococcal Toxic-Shock-Like Syndrome (STSLS) Caused by Streptococcus suis.
    Yang C; Zhao J; Lin L; Pan S; Fu L; Han L; Jin M; Zhou R; Zhang A
    Front Cell Infect Microbiol; 2015; 5():79. PubMed ID: 26618144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterisation a surface-associated arginine peptidase in Streptococcus suis serotype 2.
    Huang K; Yuan Z; Li J; Zhang Q; Xu Z; Yan S; Zhang A; Jin M
    Microbiol Res; 2015 Jan; 170():168-76. PubMed ID: 25179447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.